| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Obstetrics and Gynecology, University of Southampton, Princess Anne Hospital, Southampton SO16 5YA [X. J., S. J. M., E. J. T., I. G. C.], and Department of Histopathology, Southampton General Hospital, Southampton SO16 6YD [A. H.], United Kingdom
Endometriosis is a common gynecological disease in which tissue similar to the endometrium proliferates at sites outside the uterine cavity. Malignant transformation of endometriosis to endometrioid and clear cell ovarian carcinomas has been documented in histological studies, but no molecular genetic evidence exists to support that endometriosis is the clonal precursor of such malignancies. We examined 14 cases of endometriosis synchronous with ovarian cancer for loss of heterozygosity on 12 chromosome arms, X chromsome inactivation, and TP53 mutation to determine whether they shared genetic alterations. In all four of the cases where the carcinoma had arisen within endometriosis and in five of the seven cases where the carcinoma was adjacent to the endometriosis, common genetic lesions were detected, consistent with a common lineage. A TP53 mutation was also detected in one case of endometriosis adjacent to carcinoma. These findings support the numerous histological observations that endometrioid and clear cell ovarian carcinomas may arise through malignant transformation of endometriotic lesions.
1 Supported by grants from Wellbeing and The Wessex Medical Trust.
2 To whom reprints should be addressed, at Obstetrics and Gynaecology, University of Southampton, Level F, Princess Anne Hospital, Coxford Road, Southampton SO16 5YA, UK.
Received 9/18/97. Accepted 2/18/98.
This article has been cited by other articles:
![]() |
K. Yamaguchi, M. Mandai, S. Toyokuni, J. Hamanishi, T. Higuchi, K. Takakura, and S. Fujii Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress Clin. Cancer Res., January 1, 2008; 14(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wren, Y. Wu, and S.-W. Guo A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vigano, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis Hum. Reprod. Update, January 1, 2006; 12(1): 77 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Campbell, S. E. Russell, W. A. Phillips, D. A. Levine, and J. Boyd PIK3CA Mutations in Ovarian Cancer Clin. Cancer Res., October 1, 2005; 11(19): 7042 - 7043. [Full Text] [PDF] |
||||
![]() |
I. G. Campbell, S. E. Russell, D. Y. H. Choong, K. G. Montgomery, M. L. Ciavarella, C. S. F. Hooi, B. E. Cristiano, R. B. Pearson, and W. A. Phillips Mutation of the PIK3CA Gene in Ovarian and Breast Cancer Cancer Res., November 1, 2004; 64(21): 7678 - 7681. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-C. Lin, J.-M. Chen, and C.-H. Tsai Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis Mol. Hum. Reprod., October 1, 2004; 10(10): 713 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lattuada, P. Vigano, E. Somigliana, A. Abbiati, M. Candiani, and A.M. Di Blasio Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis Mol. Hum. Reprod., September 1, 2004; 10(9): 651 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Varma, T. Rollason, J. K Gupta, and E. R Maher Endometriosis and the neoplastic process Reproduction, March 1, 2004; 127(3): 293 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Harada, A. Kaponis, T. Iwabe, F. Taniguchi, G. Makrydimas, N. Sofikitis, M. Paschopoulos, E. Paraskevaidis, and N. Terakawa Apoptosis in human endometrium and endometriosis Hum. Reprod. Update, January 1, 2004; 10(1): 29 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Tung, M. T. Goodman, A. H. Wu, K. McDuffie, L. R. Wilkens, L. N. Kolonel, A. M. Y. Nomura, K. Y. Terada, M. E. Carney, and L. H. Sobin Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study Am. J. Epidemiol., October 1, 2003; 158(7): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, X. Zhang, and Y. Chen Mutagen sensitivity as a susceptibility marker for endometriosis Hum. Reprod., October 1, 2003; 18(10): 2052 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Modesitt, G. Tortolero-Luna, J. B. Robinson, D. M. Gershenson, and J. K. Wolf Ovarian and Extraovarian Endometriosis-Associated Cancer Obstet. Gynecol., October 1, 2002; 100(4): 788 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Ismail, S Vandeginste, and R W Shaw An unusually aggressive case of endometriosis showing p53 expression J. Clin. Pathol., May 1, 2001; 54(5): 396 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology Endocr. Rev., April 1, 2001; 22(2): 255 - 288. [Abstract] [Full Text] |
||||
![]() |
S.W. Baxter, E.J. Thomas, and I.G. Campbell GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer Carcinogenesis, January 1, 2001; 22(1): 63 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, T. Kubo, and M. Noguchi Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary Cancer Res., December 1, 2000; 60(24): 7052 - 7056. [Abstract] [Full Text] |
||||
![]() |
X. Matias-Guiu, E. Bussaglia, L. Catasus, H. Lagarda, E. Gras, P. Machin, J. Prat, W. M. Lin, and C. Y. Muller Correspondence re: W. M. Lin et al., Loss of Heterozygosity and Mutational Analysis of the PTEN/MMAC1 Gene in Synchronous Endometrial and Ovarian Carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998. Clin. Cancer Res., April 1, 2000; 6(4): 1598 - 1600. [Full Text] |
||||
![]() |
L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |